T-Cell Lymphoma and Secondary Primary Malignancy Risk after Commercial CAR T-Cell Therapy

The T cell lymphoma (TCL) was diagnosed from a thoracic lymph node upon surgery for lung cancer. The TCL exhibited CD8+ cytotoxic phenotype and a JAK3 variant, while the CAR transgene was very low.